Swiss firm Lonza said Wednesday it will open a new production line for the drug substance in Moderna’s COVID-19 vaccine, making it possible to churn out hundreds of millions more jabs per year. The...

Researchers from Trinity College Dublin have developed a novel set of tools for designing vitamin D clinical trials that capture large seasonal and population-wide differences in vitamin D status, typically...

A lack of transparency in COVID-19 vaccine trials and deals signed between governments and drug companies could undermine the global response to the pandemic, warn researchers at the University of Toronto...

Prevention is better than cure—but when it comes to Covid, what happens when people can’t get the vaccine, don’t want it, or they’re immune suppressed and it fails to stop infection? The...

An international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della Svizzera italiana, has deciphered the T cell responses occurring during COVID-19...

The European Medicines Agency will announce on Friday whether it has approved the Pfizer/BioNTech coronavirus jab for 12- to 15-year-olds, the regulator said. If approved it will be the first vaccine...

MUSC Hollings Cancer Center researchers are exploring the use of peptide carriers for the delivery of small RNA drugs as a novel treatment for cancer. The team’s recent work, published online March...

A diet that improves the biomarkers of metabolic health, and that could potentially slow the aging process, has moved a step closer to reality. “We’ve known for years that restricting the...

Michael Mina is assistant professor of epidemiology at the Harvard T.H. Chan School of Public Health, a member of the School’s Center for Communicable Disease Dynamics, and associate medical director...

Scientists at The University of Manchester have developed a more efficient method to produce medicines that are in development for the treatment of COVID-19, cancer and other diseases that affect many...